Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVA-PEF: Ivabradine in Heart Failure with Preserved Ejection Fraction
jRCTs051200059Completed
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ivabradine in heart failure with preserved ejection fraction (HFpEF), left ventricular diastolic dysfunction (LVDD) and heart failure (HF). Primary endpoint: Change in E/e'. Started Nov 2020; status: completed.
02
Drugs
ivabradine
03
Conditions
heart failure with preserved ejection fraction (HFpEF)left ventricular diastolic dysfunction (LVDD)heart failure (HF)
Beyond the preview
Go deeper on jRCTs051200059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051200059.